ENLIE Pharmaceutical JSC (HSTC:BCP) Research & Development: ₫ Mil (TTM As of . 20)


HSTC:BCP ENLIE Pharmaceutical JSC HSTC:BCP
25 GF Score
Price ₫10,600.00
View Full Analysis

What is ENLIE Pharmaceutical JSC Research & Development?

ENLIE Pharmaceutical JSC HSTC:BCP 25 Research & Development is ₫ Mil as of . 20. GuruFocus rates HSTC:BCP with a GF Score™ of 25/100.

Research & Development is the aggregate amount of research and development expenses during the year. ENLIE Pharmaceutical JSC's Research & Development for the six months ended in . 20 was ₫0.00 Mil. ENLIE Pharmaceutical JSC does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

ENLIE Pharmaceutical JSC  (HSTC:BCP) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

ENLIE Pharmaceutical JSC Research & Development Related Terms

ENLIE Pharmaceutical JSC Research & Development Historical Data

* Premium members only.

The historical data trend for ENLIE Pharmaceutical JSC's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ENLIE Pharmaceutical JSC Research & Development Chart

ENLIE Pharmaceutical JSC Annual Data
Trend
Research & Development

ENLIE Pharmaceutical JSC Semi-Annual Data
Research & Development
HSTC:BCP
25GF Score
ENLIE Pharmaceutical JSC HSTC:BCP
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ENLIE Pharmaceutical JSC Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₫ Mil mean?
ENLIE Pharmaceutical JSC (HSTC:BCP) has a Research & Development of ₫ Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on ENLIE Pharmaceutical JSC and its competitors.
Is ENLIE Pharmaceutical JSC's Research & Development too high?
ENLIE Pharmaceutical JSC's current Research & Development is ₫ Mil. Overall, ENLIE Pharmaceutical JSC has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does ENLIE Pharmaceutical JSC's Research & Development compare to ?
ENLIE Pharmaceutical JSC's Research & Development of ₫ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on ENLIE Pharmaceutical JSC and its competitors. ENLIE Pharmaceutical JSC's current Research & Development is ₫ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ENLIE Pharmaceutical JSC stock overvalued right now?
ENLIE Pharmaceutical JSC (HSTC:BCP) has a current Research & Development of ₫ Mil. The current Research & Development is ₫ Mil. ENLIE Pharmaceutical JSC's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For ENLIE Pharmaceutical JSC (HSTC:BCP), the current Research & Development is ₫ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ENLIE Pharmaceutical JSC Business Description

Comparable Companies
Address NA6 Street, My Phuoc 2 Industrial Park, Ben Cat district, Binh Duong, VNM
ENLIE Pharmaceutical JSC is engaged in the production and trading of pharmaceuticals, medical supplies, cosmetics, foods, and functional foods. It is also engaged in the wholesale of other installation materials and equipment in the construction.
25GF Score

Get the complete analysis for HSTC:BCP

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫10,600.00
Price